@article{Obregón_Echevarría_Lugo_Soto_González_2020, title={Usefulness of IgM-ELISA test for screening of Leptospirosis in Cuba}, volume={8}, url={https://ajouronline.com/index.php/AJAS/article/view/6067}, DOI={10.24203/ajas.v8i2.6067}, abstractNote={<p>Introduction: Leptospirosis is a common cause of acute febrile illness in many tropical regions of the world. Early diagnosis is essential, since untreated cases can progress rapidly and mortality rates are high in severe cases. According to the observations of the Cuban National Reference Laboratory, non-reactive serology’s are prevailing in most suspected cases of human leptospirosis. Objective: to apply the IgM-ELISA test for screening of IgM antibodies using sera from patients with the acute phase of the illness. Material and methods: in the current study, 31 pairs of sera and 140 single sera from 337 suspected patients with leptospirosis were tested by two methods, a commercial IgM-ELISA test  for Leptospira and microagglutination test (MAT). Results: IgM-ELISA test results were concordant with MAT results in 90.0% (28/31) of paired sera and 88,6% (124/140) of single sera. The following serogroups: Icterohaemorrhagiae 23,74% (18/76), Pomona 22.3% (17/76), Canicola 13.1% (10/76), and Ballum 5.2% (4/76) were the most frequently found in sera testing positive by  IgM-ELISA.  Positive IgM-ELISA sera were predominantly those taken from 5<sup>th</sup> to the 8<sup>th</sup> day of the acute phase of the illness. Some samples taken from day zero to the 28<sup>th</sup> day were also positive, suggesting a high sensitivity of this test.  Conclusion: IgM-ELISA test  is useful for screening of human leptospirosis, particularly if using sera taken from days 5-8 of surveillance, which reduce the under reporting of leptospirosis cases in Cuba.</p> <p> </p>}, number={2}, journal={Asian Journal of Applied Sciences}, author={Obregón, Ana M. and Echevarría, Eduardo and Lugo, Odisney and Soto, Yolaine and González, Liliet}, year={2020}, month={Apr.} }